Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
EBITDA
-$19.00M
Quarterly · Period ending: · USD
TEVA EBITDA
Latest reported-$19.00Mperiod ending
Latest reported-$19.00Mperiod ending
TEVA Quarterly EBITDA ($22.80M → -$19.00M)
Quarterly EBITDA
High-resolution chart · PNG
TEVA ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 86,850,000 | |
| 78,904,000 | |
| 175,953,000 | |
| 74,420,000 | |
| 93,459,000 | |
| 53,063,000 | |
| 61,615,000 | |
| 65,200,000 | |
| 41,200,000 | |
| 38,400,000 | |
| 45,900,000 | |
| 38,200,000 | |
| 20,900,000 | |
| 33,300,000 | |
| -651,200,000 | |
| 286,700,000 | |
| 270,700,000 | |
| 267,600,000 | |
| -546,800,000 | |
| 236,600,000 | |
| 250,200,000 | |
| 189,300,000 | |
| -359,600,000 | |
| 165,300,000 | |
| 156,800,000 | |
| 152,700,000 | |
| -320,400,000 | |
| 143,500,000 | |
| 146,900,000 | |
| 136,700,000 | |
| -282,700,000 | |
| 127,200,000 | |
| 125,000,000 | |
| 118,400,000 | |
| -218,800,000 | |
| 93,000,000 | |
| 93,000,000 | |
| 92,900,000 | |
| -192,300,000 | |
| 78,700,000 | |
| 77,800,000 | |
| 87,300,000 | |
| -148,800,000 | |
| 62,600,000 | |
| 69,600,000 | |
| 65,700,000 | |
| -151,600,000 | |
| 63,800,000 | |
| 68,800,000 | |
| 68,200,000 | |
| -122,200,000 | |
| 46,600,000 | |
| 50,100,000 | |
| 50,000,000 | |
| 28,500,000 | |
| 26,400,000 | |
| 34,900,000 | |
| 34,900,000 | |
| 34,900,000 | |
| -56,500,000 | |
| 22,800,000 | |
| 22,800,000 |